143 related articles for article (PubMed ID: 32634198)
41. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study.
Ekrikpo UE; Akpan EE; Ekott JU; Bello AK; Okpechi IG; Kengne AP
BMJ Open; 2018 Jul; 8(7):e019664. PubMed ID: 30030310
[TBL] [Abstract][Full Text] [Related]
42. Determinants of virological failure and antiretroviral drug resistance in Mozambique.
Rupérez M; Pou C; Maculuve S; Cedeño S; Luis L; Rodríguez J; Letang E; Moltó J; Macete E; Clotet B; Alonso P; Menéndez C; Naniche D; Paredes R
J Antimicrob Chemother; 2015 Sep; 70(9):2639-47. PubMed ID: 26084302
[TBL] [Abstract][Full Text] [Related]
43. [Lipid alterations and cardiovascular risk associated with antiretroviral therapy].
Masiá-Canuto M; Bernal-Morell E; Gutiérrez-Rodero F
Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):637-48. PubMed ID: 17194390
[TBL] [Abstract][Full Text] [Related]
44. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G
BMC Geriatr; 2018 Apr; 18(1):99. PubMed ID: 29678160
[TBL] [Abstract][Full Text] [Related]
45. Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD).
Bijker R; Jiamsakul A; Uy E; Kumarasamy N; Ditango R; Chaiwarith R; Wong WW; Avihingsanon A; Sun LP; Yunihastuti E; Pujari S; Do CD; Merati TP; Kantipong P; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Ng OT; Sim B; Ross J; Kiertiburanakul S;
HIV Med; 2019 Mar; 20(3):183-191. PubMed ID: 30620108
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study.
Agu CE; Uchendu IK; Nsonwu AC; Okwuosa CN; Achukwu PU
BMC Public Health; 2019 Aug; 19(1):1143. PubMed ID: 31429736
[TBL] [Abstract][Full Text] [Related]
48. Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Dana T; Grusing S; Bougatsos C
JAMA; 2019 Jun; 321(23):2337-2348. PubMed ID: 31184705
[TBL] [Abstract][Full Text] [Related]
49. Compromise of Second-Line Antiretroviral Therapy Due to High Rates of Human Immunodeficiency Virus Drug Resistance in Mozambican Treatment-Experienced Children With Virologic Failure.
Vaz P; Buck WC; Bhatt N; Bila D; Auld A; Houston J; Cossa L; Alfredo C; Jobarteh K; Sabatier J; Macassa E; Sousa A; DeVos J; Jani I; Yang C
J Pediatric Infect Dis Soc; 2020 Feb; 9(1):6-13. PubMed ID: 30364958
[TBL] [Abstract][Full Text] [Related]
50. PMTCT care cascade and factors associated with attrition in the first four years after Option B+ implementation in Mozambique.
Ahoua L; Tiendrebeogo T; Arikawa S; Lahuerta M; Aly D; Journot V; Abrams EJ; Becquet R; Dabis F
Trop Med Int Health; 2020 Feb; 25(2):222-235. PubMed ID: 31667997
[TBL] [Abstract][Full Text] [Related]
51. Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000.
Braitstein P; Yip B; Heath KV; Levy AR; Montaner JS; Humphries K; Kiely FM; O'Shaughnessy MV; Hogg RS
AIDS; 2003 Sep; 17(14):2071-5. PubMed ID: 14502010
[TBL] [Abstract][Full Text] [Related]
52. Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy.
Domingues EA; Ferrit-Martín M; Calleja-Hernández MÁ
Int J Clin Pharm; 2017 Feb; 39(1):52-60. PubMed ID: 27864732
[TBL] [Abstract][Full Text] [Related]
53. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.
Ferrara M; Umlauf A; Sanders C; Meyer JM; Allen McCutchan J; Duarte N; Hampton Atkinson J; Grant I; Ellis RJ;
Psychiatry Res; 2014 Aug; 218(1-2):201-8. PubMed ID: 24794030
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
[TBL] [Abstract][Full Text] [Related]
55. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.
Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P
Glob Health Action; 2016; 9():29943. PubMed ID: 26765104
[TBL] [Abstract][Full Text] [Related]
56. Patterns of mobility and its impact on retention in care among people living with HIV in the Manhiça District, Mozambique.
Bernardo EL; Nhampossa T; Clouse K; Carlucci JG; Fernández-Luis S; Fuente-Soro L; Nhacolo A; Sidat M; Naniche D; Moon TD
PLoS One; 2021; 16(5):e0250844. PubMed ID: 34019556
[TBL] [Abstract][Full Text] [Related]
57. Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study.
Rodríguez-Arbolí E; Mwamelo K; Kalinjuma AV; Furrer H; Hatz C; Tanner M; Battegay M; Letang E;
PLoS One; 2017; 12(3):e0172089. PubMed ID: 28273105
[TBL] [Abstract][Full Text] [Related]
58. Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa.
Brennan AT; Bonawitz R; Schnippel K; Berhanu R; Maskew M; Long L; Bassett J; Sanne I; Fox MP
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1040-5. PubMed ID: 27393537
[TBL] [Abstract][Full Text] [Related]
59. Adherence to antiretroviral therapy and associated factors among HIV positive adults attending care and treatment in University of Gondar Referral Hospital, Northwest Ethiopia.
Molla AA; Gelagay AA; Mekonnen HS; Teshome DF
BMC Infect Dis; 2018 Jun; 18(1):266. PubMed ID: 29879913
[TBL] [Abstract][Full Text] [Related]
60. Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients?: A cross sectional study.
Carey RA; Rupali P; Abraham OC; Kattula D
J Postgrad Med; 2013; 59(4):258-62. PubMed ID: 24346381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
